This is Nick Kristoff.
I'm an opinion columnist for The New York Times, and I'm proud that for more than 100 years,
The Times has conducted an annual appeal to raise money for charitable organizations.
Times journalism is fundamentally about vetting the truth, and in this case,
about vetting organizations and selecting some of the best to help create opportunity and overcome hardship.
I hope you'll consider donating to The New York Times Communities Fund To learn more,
go to nytimes.com slash nytfund.
Thank you.
We return to the story of one married couple's experience with GLP-1 drugs and how the use of weight loss medications like Osempic can impact how people see themselves and their closest relationships.
It's Friday, December 26th.
Lisa,
I don't think it's an understatement to say that we in 2025 are in the middle of this what feels like kind of a weight loss revolution in the United States.
And of course, we're talking about these drugs that everybody's probably heard of,
Osempic, We Govee, Monjaro.
I think most people know somebody who's been transformed by them.
Maybe a lot of people themselves have actually had some experience with them.
Yeah, it's a revolution in how we look.
It's a revolution in our health.
It's got...
gigantic potential to help people who have not been able to be helped before.